Enzyme inhibitor screening using a homogeneous proximity-based immunoassay for estradiol

Journal of Biomolecular Screening

Volumn 10, Issue 4, 2005, Pages 348-354

  Kokko, Leena ^a   Johansson, Nina ^b   Lövgren, Timo ^a   Soukka, Tero ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b Hormos Medical Ltd   (Finland)

Author keywords

Europium(III) chelate nanoparticle; High throughput screening; Homogeneous; Time resolved fluorometry

Indexed keywords

ESTRADIOL; ESTRONE; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG SCREENING; ENZYME MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

17-HYDROXYSTEROID DEHYDROGENASES; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INHIBITORS; ESTRADIOL; FEASIBILITY STUDIES; HUMANS; IMMUNOASSAY;

MINK CELL FOCUS-FORMING VIRUS;

EID: 20444410379     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057104272191     Document Type: Article

References (19)

1. Scott JE, Carpenter JW: A homogeneous assay for kinase activity that detects phosphopeptide using fluorescence polarization and zinc. Anal Biochem 2003;316:82-91
2. Gagne A, Banks P, Hurt SD: Use of fluorescence polarization detection for the measurement of fluopeptietm binding to G protein-coupled receptors. J Recept Signal Transduct Res 2002;22:333-343.
3. Fernandes P: Technological advances in high-throughput screening. Curr Opin Chem Biol 1998;2:597-603.
4. Eggeling C, Brand L, Ullmann D, Jäger S: Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov Today 2003;8:632-641.
5. Penning TM: Molecular endocrinology of hydroxysteroid dehydrogenases. Endocrinol Rev 1998;18:281-305.
6. Miettinen MM, Mustonen MVJ, Poutanen MH, Isomaa VV, Vihko RK: Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities in cultured cells and characteristic cell- and tissue-specific expression. Biochem J 1996;314:839-845.
7. Miyoshi Y, Ando A, Shiba E, Tagushi T, Tamaki Y, Noguchi S: Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers. Int J Cancer 2001;94:685-689.
8. Lippert C, Seeger H, Mueck AO: The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 2003;72:877-883.
9. Boisclair MD, McClure C, Josiah S, Glass S, Bottomley S, Kamerkar S, et al: Development of a ubiquitin transfer assay for high throughput screening by fluorescence resonance energy transfer. J Biomol Screen 2000;5:319-328.
10. Enomoto K, Aono Y, Mitsugi T, Takahashi K, Suzuki R, Préaudat M, et al: High throughput screening for human interferon-γ production inhibitor using homogeneous time-resolved fluorescence. J Biomol Screen 2000;5:263-268.
11. Kokko L, Sandberg K, Lövgren T, Soukka T: Europium(III) chelate-dyed nanoparticles as donors in a homogeneous proximity-based immunoassay for estradiol. Anal Chim Acta 2004;503:155-162.
12. Sekatskii SK, Dietler G: Using magnetic dipole transitions for fluorescence resonance energy trasfer. Anal Biochem 2001;299:263-266.
13. Härmä H, Soukka T, Lövgren T: Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen. Clin Chem 2001;47:561-568.
14. Lamminmaki U, Westerlund-Karlsson A, Toivola M, Saviranta P: Modulating the binding properties of an anti-17β-estradiol antibody by systematic mutation combinations. Protein Sci 2003;12:2549-2558.
15. Miettinen MM, Poutanen MH, Vihko RK: Characterization of estrogen-dependent growth of cultured MCF-7 human breast-cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1. Int J Cancer 1996;68:600-604.
16. Zhang JH, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
17. Ekins R, Edwards P: On the meaning of "sensitivity." Clin Chem 1997;43:1824-1837.
18. Rodbard D, Ruder HJ, Vaitukaitis J, Jacobs HS: Mathematical analysis of kinetics of radioligand assays: improved sensitivity obtained by delayed addition of labeled ligand. J Clin Endocrinol Metab 1971;33:343-355.
19. Piran U, Silbert-Shostek D, Barlow EH: Role of antibody valency in haptenheterologous immunoassays. Clin Chem 1993;39:879-883.